6th Translational Research Conference: Lymphoid Malignancies

6^th ESH Translational Research Conference
LYMPHOID MALIGNANCIES
#ESHLYMPHOID2021

GOING VIRTUAL
NEW DATES: October 14-17, 2021– E-CONFERENCE

​https://lymphoid-2021.esh.live/​

Main Entrance

Chairs: Michael Hallek (Cologne), Georg Lenz (Münster), Laurie Sehn (Vancouver), Louis Staudt (Bethesda)

Advisory Board: Barbara Eichhorst (Cologne), Ricardo Dalla-Favera (New-York), Frank Morschhauser (Lille), Laura Pasqualucci (New York), Stephan Stilgenbauer (Ulm), Andrei Thomas-Tikhonenko (Philadelphia)

ABOUT THE CONFERENCE:

In view of continuing COVID-19 related challenges, the ESH “6th Translational Research Conference: Lymphoid Malignancies” will be held as a virtual event.

REGISTRATION IS OFFERED FREE OF CHARGE as a gesture of solidarity during these difficult times.

ABOUT THE PROGRAMME:

This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.

The goals of this conference are to:

– foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide.
– foster scientific cross-fertilization between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment.
– provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training

A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of Lymphoid Malignancies.

 
LEARNING OBJECTIVES:

Improved understanding of :
– current developments in the field of molecular pathogenesis of indolent and aggressive B-cell lymphoma including CLL
– current developments in the field of the molecular pathogenesis of T-cell lymphoma
– prognostic and predictive markers and their impact in specific clinical situations
– current treatments and future therapeutic perspectives.

SCIENTIFIC TOPICS:

– B-cell development and lymphomagenesis
– Genetics of malignant lymphomas and clonal evolution
– Epigenetics in malignant lymphomas
– Deregulated proteome and metabolome
– Single cell analyses, circulating tumor DNA, MRD
– Oncogenic signaling pathways
– Utilizing oncogenic signaling therapeutically
– Immunologic approaches in the treatment of lymphomas

The programme will include:

– Plenary Sessions
– Simultaneous Meet the Experts Sessions (fully live)
– Round Table Discussions
– Brief Oral Communications
– Mentored Poster Walk (fully live)
– Ample time for in-depth discussion (fully live)

ABSTRACTS SUBMISSION IS NOW CLOSED

Abstracts:

• Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured. 
• Maximum number of words: 500 
• Your abstract will be submitted to peer review.

TO ACCESS THE E-CONFERENCE PLATFORM, CLICK HERE!

TAKE A VIRTUAL TOUR OF THE E-CONFERENCE PLATFORM

With the support of*:

Premium E-Conference Partners

*********

Diamond E-Conference Partners

*********

Emerald E-Conference Partner

*********

Ruby E-Conference Partner

*********

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

The registration fee for the 6th Translational Research E-Conference: Lymphoid Malignancies is free.

REGISTRATION IS NOW OPEN! 

Meet the Expert sessions: Registration fee: 20€
These sessions will be open to E-Conference academic biologists and clinicians registrants only. A maximum of 30 seats will be available in each session and pre-registration will therefore be required. REGISTRATION OPENINF CLOSER TO THE E-CONFERENCE

Register Here